You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
MDPI is excited to announce a special webinar in celebration of World Hepatitis Day on 28 July 2026. This event aims to share the latest insights and innovations driving progress towards a future free from viral hepatitis.
Date: 28 July at 11:00 a.m. CEST | 5:00 a.m. EDT| 5:00 p.m. CST Asia
Webinar ID: 871 1085 3319
Website: https://sciforum.net/event/MWHDW2026-1
Register now for free!
Program:
| Speaker | Presentation Title | Time in CEST | Time in EDT | Time in CST (Asia) |
| MDPI Introduction | 11:00–11:10 a.m. | 5:00–5:10 a.m. | 5:00–5:10p.m. | |
| Prof. Dr. Ferruccio Bonino | A Functional Cure for Hepatitis B Virus (HBV) Infection: A Turning Point for the Elimination of a Persistent Major Global Burden | 11:10–11:30 a.m. | 5:10–5:30 a.m. | 5:10–5:30 p.m. |
| Prof. Dr. Rosimar Neris Martins-Feitosa | Importance of Investigating Coinfection by Human T-Lymphotropic Viruses 1 and 2 in Individuals Infected with Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV) | 11:30–11:50 a.m. | 5:30–5:50 a.m. | 5:30–5:50 p.m. |
| Q&A Session | 11:50 a.m.–12:10 p.m. | 5:50–6:10 a.m. | 5:50–6:10 p.m. | |
| Webinar Closing | 12:10–12:20 p.m. | 6:10–6:20 a.m. | 6:10–6:20 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic and institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Keynote Speakers: